Clinical Trial Update: Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating precision exercise prescription for lung cancer patients undergoing surgery has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Utah | Conditions: Non Small Cell Lung Cancer, Secondary Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2026-06-09